SMS Pharmaceuticals Ltd

SMS Pharmaceuticals announced its financial results for the quarter ending December 2024, highlighting a strong operating profit to interest ratio and significant growth in profit after tax. However, the company also reported a decline in net sales, indicating a mixed financial performance amid evolving market conditions.

SMS Pharmaceuticals has shown significant trading activity today, rebounding after two days of decline. The stock opened lower but quickly rose, reaching an intraday high. It has experienced high volatility, with notable fluctuations, and is currently positioned above its short-term moving averages while remaining below longer-term ones.

SMS Pharmaceuticals' stock has declined significantly, dropping 7.68% on January 28, 2025, and experiencing a total loss of 12.19% over three days. The company is trading below its moving averages and has seen a 21.46% decrease over the past month, indicating ongoing market challenges.

SMS Pharmaceuticals has experienced a revision in its score by MarketsMOJO, reflecting a shift in evaluation amid mixed financial performance. Despite reporting significant profit growth and increased net sales, concerns over long-term growth prospects have influenced this adjustment. The stock has also been added to MarketsMOJO's list, highlighting its consistent performance over recent quarters.

SMS Pharmaceuticals has recently undergone a revision in its score, reflecting the stock's ongoing challenges in the Pharmaceuticals & Drugs sector. Following a significant decline in performance, the stock has been added to MarketsMOJO's list, highlighting a shift in its market position. Investors will be closely watching future developments.

SMS Pharmaceuticals has recently undergone a revision in its score, reflecting its strong performance in the pharmaceuticals sector. The stock has been added to MarketsMOJO's list, following a notable increase in value and a positive trend that outpaced the sector. Despite some fluctuations, SMS Pharmaceuticals continues to show resilience in the market.

On November 26, 2024, SMS Pharmaceuticals, a smallcap pharmaceutical company, saw a significant increase in its stock price, gaining 8.64% and outperforming the sector by 4.42%. The stock has been on an upward trend for the past three days, with a 7.28% increase in returns. However, it is currently trading higher than its 5-day and 200-day moving averages, but lower than its 20-day, 50-day, and 100-day moving averages, indicating a mixed trend. It has outperformed the Sensex by 7.90% in the past day and underperformed by -4.53% in the past month. MarketsMOJO has given a 'Hold' call for the stock, suggesting a cautious approach for investors.

The company's PAT and Net Sales have shown significant growth, and its Debt-Equity Ratio is at its lowest in the last five half-yearly periods.

On October 7th, 2024, SMS Pharmaceuticals, a smallcap pharmaceutical company, experienced a -7.44% decline in its stock price. This was noted by MarketsMOJO, who has given a 'Hold' call for the stock. Despite the recent decline, the company's moving averages are still higher than the 50-day, 100-day, and 200-day moving averages. However, it is currently lower than the 5-day and 20-day moving averages. In comparison to the Sensex, SMS Pharmaceuticals' performance on the day of the decline was -7.44%, while the Sensex's performance was -0.78%. Over the past month, SMS Pharmaceuticals has seen a 1.08% increase, while the Sensex has seen a -0.16% decrease.

SMS Pharmaceuticals, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 23, 2024. It has outperformed the sector by 4.78% today and has shown consecutive gains in the last 3 days, with an intraday high of Rs 389.75. The stock has also shown a remarkable performance in the past year, with a 214.05% increase, indicating strong growth potential in the pharmaceutical industry.

SMS Pharmaceuticals, a smallcap pharmaceutical company, has been performing well in the stock market, with its stock price reaching a 52-week high of Rs 363.1 on September 11, 2024. According to MarketsMOJO, the current stock call for SMS Pharmaceuticals is 'Hold' and it has outperformed the sector by 3.34% in today's trading session. The stock has also shown consecutive gains in the last 3 days and is currently trading above its moving averages. With a 190.21% increase in its stock price in the past year, SMS Pharmaceuticals is proving to be a strong player in the market.

On September 11, 2024, SMS Pharmaceuticals, a smallcap company in the pharmaceuticals and drugs industry, saw a 7.06% increase in its stock price. With a 'Hold' rating from MarketsMOJO, the stock has been trading close to its 52-week high and has outperformed the sector and market in the past month.

SMS Pharmaceuticals, a smallcap company in the pharmaceutical industry, has reached a new milestone as its stock price hit a 52-week high of Rs. 337.15 on August 23, 2024. With a 'Hold' call from MarketsMOJO, the stock has shown a strong performance, outperforming the sector by 9.79%. It is currently trading higher than its moving averages and has shown a remarkable growth of 156.15% in the past year.

On August 23, 2024, SMS Pharmaceuticals, a smallcap company in the pharma industry, saw a 9.38% increase in its stock price, closing at Rs. 337.15, its new 52-week and all-time high. This was driven by positive market sentiment and strong company performance. MarketsMOJO has given a 'Hold' call for the stock, indicating steady future performance.

On August 6th, 2024, SMS Pharmaceuticals, a smallcap company in the pharmaceutical industry, saw a decline in its stock price by -7.7%. This was reflected in the stock call given by MarketsMOJO, which rated it as 'Hold'. The stock's performance has underperformed the sector by -7.39%, with a 4.24% gain and 7.18% decline in intraday high and low respectively. Despite this, the stock's moving averages are still higher than the 20, 50, 100, and 200 day averages, but lower than the 5 day average. In comparison to the Sensex, SMS Pharmaceuticals' performance is -8.18% in 1 day and 9.28% in 1 month, while the Sensex's performance is -0.33% and -1.87% respectively.

SMS Pharmaceuticals, a smallcap company in the pharmaceutical industry, has reported a 116.97% growth in Profit After Tax (PAT) for the quarter ending June 2024. The company's Operating Profit to Interest ratio has also improved, while its Debt-Equity Ratio has decreased. However, there is a decline in Net Sales and Debtors Turnover Ratio, indicating areas for improvement. MarketsMOJO recommends holding the stock.